We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The TANSNIP-PESA trial is not the end of the story.
- Authors
Näslund, Ulf; Norberg, Margareta; Wennberg, Patrik
- Abstract
This commentary refers to 'Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial', by I. Garcia-Lunar I et al. i , https://doi.org/10.1093/eurheartj/ehac378 and the discussion piece 'Motivational interview and imaging of subclinical atherosclerosis for cardiovascular disease prevention: a winning combination? Important is also that the intervention effect in VIPVIZA was greatest in people without university education and with moderate to high CVD risk according to SCORE and Framingham Risk Score - groups which to a great extent were not represented in the TANSNIP-PESA trial.
- Subjects
MOTIVATIONAL interviewing; CAROTID artery ultrasonography; DISEASE risk factors; HEALTH behavior; ATHEROSCLEROTIC plaque
- Publication
European Heart Journal, 2023, Vol 44, Issue 17, p1574
- ISSN
0195-668X
- Publication type
Article
- DOI
10.1093/eurheartj/ehad135